Literature DB >> 27350649

Using epigenetic networks for the analysis of movement associated with levodopa therapy for Parkinson's disease.

Alexander P Turner1, Michael A Lones2, Martin A Trefzer3, Stephen L Smith4, Stuart Jamieson5, Jane E Alty6, Jeremy Cosgrove7, Andy M Tyrrell8.   

Abstract

Levodopa is a drug that is commonly used to treat movement disorders associated with Parkinson's disease. Its dosage requires careful monitoring, since the required amount changes over time, and excess dosage can lead to muscle spasms known as levodopa-induced dyskinesia. In this work, we investigate the potential for using epiNet, a novel artificial gene regulatory network, as a classifier for monitoring accelerometry time series data collected from patients undergoing levodopa therapy. We also consider how dynamical analysis of epiNet classifiers and their transitions between different states can highlight clinically useful information which is not available through more conventional data mining techniques. The results show that epiNet is capable of discriminating between different movement patterns which are indicative of either insufficient or excessive levodopa.
Copyright © 2016 The Author(s). Published by Elsevier Ireland Ltd.. All rights reserved.

Entities:  

Keywords:  Artificial gene regulatory networks; Classification; Epigenetics; Parkinson's disease; epiNet

Mesh:

Substances:

Year:  2016        PMID: 27350649     DOI: 10.1016/j.biosystems.2016.05.005

Source DB:  PubMed          Journal:  Biosystems        ISSN: 0303-2647            Impact factor:   1.973


  1 in total

Review 1.  Artificial intelligence applications and robotic systems in Parkinson's disease (Review).

Authors:  Lacramioara Perju-Dumbrava; Maria Barsan; Daniel Corneliu Leucuta; Luminita C Popa; Cristina Pop; Nicoleta Tohanean; Stefan L Popa
Journal:  Exp Ther Med       Date:  2021-12-17       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.